SHAZ is trading 6.6% down at $75.43 following a critical short report from Bleecker Street and mounting dilution concerns.
- Bleecker Street Research disclosed a short position, questioning SharonAIβs revenue projections and funding structure.
- The stock is facing additional pressure from share issuance, note conversions, and a prospectus for additional resale shares, reinforcing a significant supply overhang.